AlphaCrest Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-77,224
| Closed | -$328K | – | 1377 |
|
|
2022
Q2 | $328K | Sell |
77,224
-6,700
| -8% | -$28.5K | 0.02% | 1087 |
|
|
2022
Q1 | $798K | Buy |
83,924
+67,714
| +418% | +$644K | 0.04% | 653 |
|
|
2021
Q4 | $308K | Buy |
+16,210
| New | +$308K | 0.01% | 1253 |
|
|
2021
Q3 | – | Sell |
-27,227
| Closed | -$1.06M | – | 1380 |
|
|
2021
Q2 | $1.06M | Buy |
+27,227
| New | +$1.06M | 0.05% | 645 |
|
|
2020
Q4 | – | Sell |
-12,600
| Closed | -$337K | – | 1268 |
|
|
2020
Q3 | $337K | Buy |
12,600
+1,400
| +13% | +$37.4K | 0.04% | 803 |
|
|
2020
Q2 | $218K | Sell |
11,200
-70,900
| -86% | -$1.38M | 0.04% | 797 |
|
|
2020
Q1 | $808K | Buy |
82,100
+38,000
| +86% | +$374K | 0.1% | 360 |
|
|
2019
Q4 | $490K | Buy |
+44,100
| New | +$490K | 0.04% | 798 |
|